Mark Larché - Concepedia

Author

Mark Larché

McMaster University ORCID

Also Known As

Edward M. Conway, Helen Neighbour, Larché, M J Larche, M Larche, M Larché, M. LARCHE, M. LARCHÉ, M. Larche, M. Larchè

206

Publications

9.5K

Citations

H-Index

Concepts

All Affiliations

McMaster University Imperial College London St. Joseph’s Healthcare Hamilton Circassia Pharmaceuticals (United Kingdom)Lung Institute

About

Mark Larché is an author at McMaster University specializing in medicine, immunology, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	1.7K
2	Allergy	18	20	1.5K
3	Allergy Medicine	9	9	391
4	Engineering	1	1	147
5	Public Health	1	1	40

Mark Larché

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics Marc Humbert, J Barkans, Christopher J. Corrigan, The Journal of Immunology	1997	411
Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial WLG Oldfield, Mark Larché, A B Kay The Lancet InflammationAllergyT-cell PeptidesMedicineImmunology	2002	349
Immunoglobulin E–independent Major Histocompatibility Complex–restricted T Cell Peptide Epitope–induced Late Asthmatic Reactions Brigitte Haselden, A B Kay, Mark Larché The Journal of Experimental Medicine	1999	332
Functional rather than immunoreactive levels of IgG<sub>4</sub> correlate closely with clinical response to grass pollen immunotherapy Mohamed H. Shamji, Christian Ljørring, James N. Francis, Allergy	2011	285
Tregs and allergic disease Douglas S. Robinson, Mark Larché, Stephen R. Durham Journal of Clinical Investigation	2004	250
Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Nigel Courtenay-Luck, Agamemnon A. Epenetos, Richard E. Moore, PubMed Secondary Immune ResponsesImmunocytochemical TechniqueImmunologyPathologyImmunotherapeutics	1986	209
Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression John D. Campbell, Karen Buckland, Sarah J. McMillan, The Journal of Experimental Medicine	2009	207
Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study Deepen Patel, Peter Couroux, Pascal Hickey, Journal of Allergy and Clinical Immunology	2012	199
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia Ishac Nazi, John G. Kelton, Mark Larché, Blood	2013	185
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy Margitta Worm, Hae‐Hyuk Lee, Jörg Kleine‐Tebbe, Journal of Allergy and Clinical Immunology VaccinationVeterinary VaccinePeptide Immunotherapy VaccineAllergyPreliminary Clinical Evaluation	2011	174

Page 1